login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
JOURNEY MEDICAL CORP (DERM) Stock News
USA
-
Nasdaq
- NASDAQ:DERM -
US48115J1097
-
Common Stock
7.93
USD
+0.12 (+1.54%)
Last: 12/5/2025, 8:14:08 PM
7.93
USD
0 (0%)
After Hours:
12/5/2025, 8:14:08 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DERM Latest News, Press Relases and Analysis
All
Press Releases
24 days ago - By: Zacks Investment Research
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics
24 days ago - By: Zacks Investment Research
- Mentions:
MDWD
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
24 days ago - By: Benzinga
- Mentions:
INTS
LPTX
CMND
ADIL
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
24 days ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
26 days ago - By: Zacks Investment Research
- Mentions:
GRDN
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
a month ago - By: Zacks Investment Research
- Mentions:
ECOR
electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
NXRT
HOPE
New Strong Sell Stocks for September 4th
4 months ago - By: Benzinga
Examining the Future: Journey Medical's Earnings Outlook
a month ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
a month ago - By: Zacks Investment Research
- Mentions:
OABI
OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates
a month ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
2 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation to Participate in October 2025 Investor Conferences
3 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation to Participate in September 2025 Investor Conferences
4 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation to Present at the Emerging Growth Conference
4 months ago - By: Zacks Investment Research
- Mentions:
PRPH
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
4 months ago - By: Zacks Investment Research
- Mentions:
GILD
INO
ZVRA
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
4 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
4 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
4 months ago - By: Zacks Investment Research
- Mentions:
NKTR
Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
5 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
6 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
6 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
6 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
7 months ago - By: Zacks Investment Research
- Mentions:
IPSC
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
7 months ago - By: Journey Medical Corporation
- Mentions:
FBIO
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
7 months ago - By: Zacks Investment Research
- Mentions:
AUPH
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates
7 months ago - By: Zacks Investment Research
- Mentions:
JYNT
The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates
Please enable JavaScript to continue using this application.